Comment on Smithson et al.'s review of stimulant medication usage to improve neurocognitive and learning outcomes in childhood brain tumour survivors

Eur J Cancer. 2014 May;50(8):1566-8. doi: 10.1016/j.ejca.2014.01.032. Epub 2014 Mar 24.

Authors

Heather M Conklin¹, Wilburn E Reddick², Raja B Khan³

Affiliations

¹ Department of Psychology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States. Electronic address: heather.conklin@stjude.org.
² Department of Radiological Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
³ Department of Pediatric Medicine, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.

PMID: 24675286
DOI: 10.1016/j.ejca.2014.01.032

No abstract available

Publication types

Letter
Comment

MeSH terms

Brain Neoplasms / physiopathology*
Central Nervous System Stimulants / therapeutic use*
Cognition / drug effects*
Female
Humans
Learning / drug effects*
Male
Methylphenidate / therapeutic use*

Substances

Central Nervous System Stimulants
Methylphenidate